Navigation Links
SHL to Invest 40 Million USD in 2013 to Significantly Expand Production Facilities
Date:2/25/2013

Taoyuan, Taiwan (PRWEB) February 25, 2013

SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices such as auto injectors and pen injectors, SHL has continued to invest heavily in facilities, advanced machinery and R&D. With the rapid growth of the biologic injectable market, device suppliers are under pressure to broaden the range of services that they can provide. SHL has responded by making significant capital investments such as the 40 Million USD that will be spent this year alone.

CEO Roger Samuelsson commented, “Five years ago I signed a letter of intent with the Taiwan government promising to invest 100 Million USD here. We kept our promise and even completed that investment early. Now we will spend another 40 Million USD for 2013. Our auto injector business is one of the key drivers to this expansion of production capacity. Our customers are bringing more biologics to market and SHL is going to ensure that we meet their needs.”

This year SHL will invest primarily in molding, material handling, assembly and automation capabilities. Production will be ramped up at several facilities in Taiwan, Taoyuan One and various NanKan sites. Increased capacity will allow SHL the flexibility to provide higher quantities of devices each month. In addition to auto injectors, SHL produces pen injectors, infusors and inhaler systems. The company now has well over 2,200 staff globally and will be hiring several hundred new employees in Taiwan this year.

About SHL

SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 2,200 staff globally, with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.

SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. FibeRio® Technology Corporation Announces Strategic Investment Financing Led by SABIC and Aster Capital
2. VIC Investor Network to Significantly Accelerate Technology Company Growth
3. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
4. PDL BioPharma to Present at Two Upcoming Investor Conferences
5. Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
6. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
7. Amarantus BioScience to Present at the 15th Annual BIO CEO & Investor Conference
8. Palatin Technologies, Inc. to Present at 15th Annual BIO CEO & Investor Conference
9. EastBridge Investment Group Announces Completion of its Merger with Cellular Biomedicine Group - Shareholder Conference Call to be held February 8th
10. Patheon Announces First Phase of Additional Investment in Milton Park, UK Facility to Expand Early Development Capabilities in Europe
11. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Governor Andrew M. Cuomo today ... 43North - the world’s largest business idea competition with ... of $1 million, six $500,000 awards and four $250,000 ... to compete for prizes that will turn ideas with ... New York region. , "Last year's successful 43North ...
(Date:3/26/2015)... 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... with certain matters, including the appointment of auditors, its ... 26, 2015 (the "Meeting") was adjourned, as previously disclosed ... 11:00 a.m. ( Toronto time). The ... that previous disclosed. The Meeting will reconvene at the ...
(Date:3/26/2015)... CINCINNATI , March 26, 2015 ... SHPG ) and Cincinnati Children,s Hospital Medical Center ... rare diseases. The goal of the collaboration is to ... diseases with high unmet medical need combining Shire,s ... expertise. As a nationally ranked hospital, Cincinnati Children,s ...
(Date:3/26/2015)... Texas (PRWEB) March 26, 2015 ReliantHeart, ... technologies, and Transonic, a supplier of precision transit-time flow ... that will greatly improve the efficiency of the ... enable LVAD patients to experience greater mobility and peace ... with the miniature flow board, will draw 1/6th of ...
Breaking Biology Technology:Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5SQI Diagnostics Inc. Announces Adjournment of Meeting 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 2Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 3Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 4Shire and Cincinnati Children's Establish Rare Disease Research Collaboration 5LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 2LVAD patients to have greater mobility and peace of mind through Transonic and ReliantHeart’s True Flow collaboration for the HeartAssist5® 3
... 12 General Research Laboratory,Inc. (GRL) and ... are,advancing their partnership initiated in July 2007 ... products, following the successful,identification of siRNA inhibitors ... of in silico and in vitro studies, ...
... SAN DIEGO, March 12 Volcano Corporation,(Nasdaq: ... (IVUS) and,functional measurement (FM) products designed to enhance ... disease, said today that it,will be participating in ... on Monday, March 17., The presentation by ...
... In this Podcast you,will learn about how plant biotechnology ... Climatic conditions such as heat or cold and ... well or badly. Because whenever these,conditions are not optimal, ... top of that the reality today is that by ...
Cached Biology Technology:Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products 2Sirnaomics and GRL Establish Partnership for the Development of Two Multi-Targeted RNAi Therapeutics Products 3Volcano Corporation Presentation at Cowen Healthcare Conference to be Webcast 2BASF Podcast - Better Harvest in Spite of Climate Stress 2BASF Podcast - Better Harvest in Spite of Climate Stress 3
(Date:3/23/2015)... --  HOYOS Labs , a leading global authentication infrastructure ... Company will demonstrate multiple biometrics-based technologies under its identity ... on March 23 through 25, 2015, in ... IEEE Biometric Open Protocol Standard; free biometrics-based consumer app, ... system. BOPS was invented by HOYOS Labs and contributed ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... Latin America . Annual estimates and ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... Calif.) Scientists have discovered that breaking a biological signaling ... of a cell. The findings could lead to new ways ... the laboratory of Joel H. Rothman, a professor in the ... Barbara. The studies were reported in the interdisciplinary journal ...
... Forest University and NanoMedica, their biotechnology company partner, ... of Health (NIH) to bring to market a ... The technology, Next-Gen Lab-on-Bead, would be the first ... sequencing technologies, making drug and diagnostics discovery significantly ...
... designed to improve core deficits in children with ... of evidence, highlighting the need for well-designed studies ... new RAND Corporation study. Researchers found that ... wide variety of interventions aimed at improving core ...
Cached Biology News:UC Santa Barbara scientists learn how to unlock the destiny of a cell: A gift for the tin man? 2NIH-funded genetic sequencing tool speeds drug discovery, disease diagnostics 2More evidence needed to support use of autism interventions 2More evidence needed to support use of autism interventions 3
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Biology Products: